Trials / Completed
CompletedNCT06986044
EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 74 (actual)
- Sponsor
- Saglik Bilimleri Universitesi · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Periodontal disease is a chronic and progressive inflammatory disease in which the hard and soft tissues that support the teeth are damaged. It is caused by the interaction between harmful bacteria and the body's immune responses, and most periodontal tissues are damaged by the body's abnormal response to these microorganisms and their products. When bacteria enter the body, immune cells (neutrophils) produce reactive oxygen species (ROS) in a process called the "respiratory burst". These ROS damage cells, causing tissue destruction through a variety of mechanisms, including DNA damage, fat oxidation and protein damage. Studies have shown that neutrophils from individuals with periodontal disease produce more ROS than neutrophils from healthy individuals. High amounts of ROS lead to oxidative damage to gum tissue, periodontal ligament and alveolar bone. Oxidative stress occurs when antioxidants in the body are insufficient or when high levels of ROS are present. Therefore, disruption of the balance between oxidant and antioxidant activities is considered an important cause of oxidative damage in periodontal tissues. Parameters such as total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) are used to determine oxidative stress. Furthermore, some enzymes such as arylesterase (ARE), heme oxygenase (HO) and nuclear factor erythroid 2-related factor 2 (NRF-2) are involved in defense mechanisms against oxidative stress. Many recent studies have shown a strong association between oxidative stress and periodontal disease.
Detailed description
This study was divided into 2 groups, 37 systemically and periodontally health individuals and 37 systemically healthy individuals with stage III grade B periodontitis were included. Clinical periodontal parameters plaque index (PI), gingival index (GI), probing pocket depth (SCD), bleeding on probing (BOP) and clinical attachment level (CAL) were recorded and saliva and serum samples were collected. ELISA method was used for analyses of TOS, TAS, OSI, ARE, HO-1, NRF-2 levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serum Total Oxidant Status | Serum total oxidant status |
| DIAGNOSTIC_TEST | Salivary Total Oxidant Status | Salivary Total Oxidant Status |
| DIAGNOSTIC_TEST | Serum Total Antioxidant Status | Serum Total Antioxidant Status |
| DIAGNOSTIC_TEST | Salivary Total Antioxidant Status | Salivary Total Antioxidant Status |
| DIAGNOSTIC_TEST | Serum Oxidative Stress Index | Serum Oxidative Stress Index |
| DIAGNOSTIC_TEST | Salivary Oxidative Stress Index | Salivary Oxidative Stress Index |
| DIAGNOSTIC_TEST | Serum Arylesterase | Serum Arylesterase |
| DIAGNOSTIC_TEST | Salivary Arylesterase | Salivary Arylesterase |
| DIAGNOSTIC_TEST | Serum Heme Oxygenase | Serum Heme Oxygenase |
| DIAGNOSTIC_TEST | Salivary Heme Oxygenase | Salivary Heme Oxygenase |
| DIAGNOSTIC_TEST | Serum Nuclear Factor Erythroid 2 Related Factor 2 | Serum Nuclear Factor Erythroid 2 Related Factor 2 |
| DIAGNOSTIC_TEST | Salivary Nuclear Factor Erythroid 2 Related Factor 2 | Salivary Nuclear Factor Erythroid 2 Related Factor 2 |
| DIAGNOSTIC_TEST | Gingival Index | Gingival Index |
| DIAGNOSTIC_TEST | Plaque Index | Plaque Index |
| DIAGNOSTIC_TEST | Bleeding on Probing Index | Bleeding on Probing Index |
| DIAGNOSTIC_TEST | Clinical Attachment Loss | Clinical Attachment Loss |
| DIAGNOSTIC_TEST | Pocket Deep | Pocket Deep |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-05-01
- Completion
- 2024-09-15
- First posted
- 2025-05-22
- Last updated
- 2025-05-22
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06986044. Inclusion in this directory is not an endorsement.